Clinical Trials in Seattle

Showing 8161-8180 of 9,312 trials

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

NCT01167829

The purpose of this study is to test how the body absorbs a new form of oral testosterone (T). On Day 1 and Day 9 there are overnight stays in the General Clinical Research Center at the University of Washington to monitor blood testosterone levels over a 24-hour period.

Healthy

University of Washington14 participantsStarted Jul 2010

Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

NCT01853254

This open-label, non-randomized, single arm study will provide treatment or re-treatment with Pegasys (peginterferon alfa-2a) as monotherapy or in combination with Copegus (ribavirin) to patients with chronic hepatitis C infection. Patients who have received prior Pegasys monotherapy or combination therapy or who were considered eligible for treatment with Pegasys in previous donor protocols will be eligible to participate in this study. Treatment will be on investigator's decision according to the approved label for up to 48 weeks, with a 24-week safety follow-up.

Hepatitis C, Chronic

Hoffmann-La Roche272 participantsStarted Sep 2003

Birmingham, Alabama, United States • La Jolla, California, United States • Long Beach, California, United States +64 more locations

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

Find Trials by Condition in Seattle

RNS® System Pivotal Study

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Safety and Efficacy Study to Treat Bacterial Vaginosis

Lobradimil and Carboplatin in Treating Children With Brain Tumors

TCAD vs. Monotherapy for Influenza A in Immunocompromised Patients

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1

Vitamin D, Diet and Activity Study

Novartis H1N1 Vaccine in Pregnant Women

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.